Generated by DeepSeek V3.2| Kidney exchange | |
|---|---|
| Name | Kidney exchange |
Kidney exchange. Also known as paired kidney donation, it is a transplant strategy designed to overcome blood type incompatibility or positive crossmatch between a willing living donor and their intended recipient. By joining multiple such incompatible pairs into a larger pool, surgeons and transplant coordinators can arrange swaps, allowing each recipient to receive a compatible organ from another donor in the exchange. This innovative approach, facilitated by sophisticated matching algorithms and national registries, has significantly expanded the living donor pool and improved outcomes for patients who might otherwise face long waits on the deceased donor list.
The conceptual foundations for this practice were laid in the 1980s, with early discussions among bioethicists and nephrologists about the logistical and moral frameworks for such swaps. The first documented successful exchange was performed in South Korea in 1991, involving two couples. Independent development of the idea occurred in the United States, where a team at Johns Hopkins Hospital led by Robert Montgomery performed the first U.S. exchange in 2000. The formation of the Alliance for Paired Kidney Donation and the launch of the National Kidney Registry in the U.S., along with the establishment of NHS Blood and Transplant's program in the United Kingdom, created the infrastructure for large-scale, multi-institutional chains. Pioneering work by economists like Alvin Roth and Tayfun Sönmez in applying market design and game theory to the matching problem was instrumental in optimizing these programs, a contribution recognized by the Nobel Memorial Prize in Economic Sciences awarded to Roth.
The process is fundamentally driven by immunological barriers. The primary hurdles are ABO incompatibility and the presence of donor-specific antibodies detected in a Luminex or complement-dependent cytotoxicity crossmatch. Before any exchange, all donors undergo rigorous evaluation at a transplant center to ensure medical suitability, including assessments of renal function, cardiovascular risk, and absence of infectious disease. The logistical core relies on centralized computer algorithms that identify optimal cycles and chains from a pool of registered pairs, maximizing the number of transplants while considering factors like HLA matching, age, and geographic distance. Key organizations facilitating this include the United Network for Organ Sharing in the U.S. and Eurotransplant in Europe.
Programs are typically categorized by their scale and structure. A **paired exchange** involves a simple swap between two incompatible pairs. A **domino paired donation** chain, often initiated by a non-directed altruistic donor, can involve multiple pairs in a sequence, with the final donor's kidney going to a patient on the waiting list. **List exchange** programs allow an incompatible donor to give a kidney to a stranger on the list in return for priority for their intended recipient. The most complex are **multi-institutional national programs**, such as those run by the National Kidney Registry or the UK Living Kidney Sharing Scheme, which utilize advanced algorithms to create long chains and cycles across many transplant centers, dramatically increasing match possibilities.
The practice navigates several complex ethical domains. Central concerns include protecting against coercion or undue financial incentive for donors, ensuring fully informed consent for all participants who must accept an organ from a stranger, and maintaining anonymity between pairs in most programs. Legal frameworks, such as the National Organ Transplant Act in the U.S., explicitly permit paired donation while prohibiting valuable consideration. Debates persist regarding the inclusion of **HIV-positive donors** to **HIV-positive recipients** in these pools and the ethical implications of **international exchanges** between countries with differing regulatory standards. The role of altruistic donors in initiating chains is widely praised but requires careful psychological evaluation.
Studies consistently show that recipients in these programs experience graft survival and patient survival rates equivalent to or better than those from compatible living donors, and significantly superior to outcomes from deceased donor transplants. The system has substantially reduced waiting times for hard-to-match patients, particularly those with blood type O or high levels of panel-reactive antibody. By enabling transplants that would not otherwise occur, it has saved billions in Medicare and Medicaid costs associated with long-term dialysis. The success has inspired similar exchange models for other organs, such as liver transplantation. Ongoing research focuses on integrating desensitization protocols with exchange algorithms and expanding global cooperation through entities like the World Health Organization to maximize the benefit of this life-saving innovation.
Category:Organ transplantation Category:Medical procedures Category:Nephrology